A new study suggests giving boys the HPV vaccine could cut health-care costs over the long run.
The researchers used mathematical modelling to estimate the effect of giving HPV vaccine to 12-year-old boys to prevent cancers of the mouth and throat.
The work suggests if all the 12-year-old boys in Canada had been vaccinated in 2012, between $8 million and $28 million might have been saved because of oropharyngeal cancers averted in that group. …
But a senior vaccine researcher questions the finding, saying the study design chosen wasn’t the right one for testing this kind of question.
Consider that the widely pushed current vaccines are effective only against some strains of HPV. Consider also that unlike childhood vaccinations for communicable diseases like measles, HPV is pretty singular in its transmission.